[go: up one dir, main page]

IL131158A0 - 4-Aminoalkoxy-1h-benzimidazole derivatives their preparation and their use as dopamine autoreceptor (d2) agonists - Google Patents

4-Aminoalkoxy-1h-benzimidazole derivatives their preparation and their use as dopamine autoreceptor (d2) agonists

Info

Publication number
IL131158A0
IL131158A0 IL13115898A IL13115898A IL131158A0 IL 131158 A0 IL131158 A0 IL 131158A0 IL 13115898 A IL13115898 A IL 13115898A IL 13115898 A IL13115898 A IL 13115898A IL 131158 A0 IL131158 A0 IL 131158A0
Authority
IL
Israel
Prior art keywords
aminoalkoxy
agonists
preparation
benzimidazole derivatives
dopamine autoreceptor
Prior art date
Application number
IL13115898A
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of IL131158A0 publication Critical patent/IL131158A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13115898A 1997-02-18 1998-01-13 4-Aminoalkoxy-1h-benzimidazole derivatives their preparation and their use as dopamine autoreceptor (d2) agonists IL131158A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80127697A 1997-02-18 1997-02-18
PCT/US1998/000613 WO1998035945A1 (en) 1997-02-18 1998-01-13 4-aminoalkoxy-1h-benzimidazole derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists

Publications (1)

Publication Number Publication Date
IL131158A0 true IL131158A0 (en) 2001-01-28

Family

ID=25180658

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13115898A IL131158A0 (en) 1997-02-18 1998-01-13 4-Aminoalkoxy-1h-benzimidazole derivatives their preparation and their use as dopamine autoreceptor (d2) agonists

Country Status (14)

Country Link
EP (1) EP0973749A1 (en)
JP (1) JP2001509814A (en)
KR (1) KR20000071129A (en)
CN (1) CN1252793A (en)
AR (1) AR011136A1 (en)
AU (1) AU746717B2 (en)
BR (1) BR9807701A (en)
CA (1) CA2278700A1 (en)
HU (1) HUP0001302A3 (en)
IL (1) IL131158A0 (en)
NZ (1) NZ336969A (en)
TW (1) TW513415B (en)
WO (1) WO1998035945A1 (en)
ZA (1) ZA981309B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541502B1 (en) * 2001-07-20 2003-04-01 Wyeth 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity
ATE529110T1 (en) * 2002-03-05 2011-11-15 Transtech Pharma Inc MONO- AND BICYCLIC AZOLE DERIVATIVES THAT INHIBIT THE INTERACTION OF LIGANDS WITH RAGE
US8580833B2 (en) 2009-09-30 2013-11-12 Transtech Pharma, Inc. Substituted imidazole derivatives and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704390A (en) * 1986-02-13 1987-11-03 Warner-Lambert Company Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents
ATE210657T1 (en) * 1994-10-14 2001-12-15 Merck Patent Gmbh CNS EFFECTIVE (R)-(-)-2-(5-(4-FLUOROPHENYL)-3-PYRIDYLMETHYLAMINOMETHYL)CHROMANE
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
DE69719765T2 (en) * 1996-08-27 2003-10-16 Wyeth, Madison 4-AMINOETHOXY INDOLDER DERIVATIVES AS DOPAMINE D2 AGONISTS AND AS 5HT1A LIGANDS

Also Published As

Publication number Publication date
ZA981309B (en) 1999-08-17
AU746717B2 (en) 2002-05-02
KR20000071129A (en) 2000-11-25
AR011136A1 (en) 2000-08-02
HUP0001302A3 (en) 2001-07-30
NZ336969A (en) 2001-03-30
HUP0001302A2 (en) 2001-05-28
CN1252793A (en) 2000-05-10
EP0973749A1 (en) 2000-01-26
CA2278700A1 (en) 1998-08-20
TW513415B (en) 2002-12-11
AU5915398A (en) 1998-09-08
JP2001509814A (en) 2001-07-24
BR9807701A (en) 2000-05-02
WO1998035945A1 (en) 1998-08-20

Similar Documents

Publication Publication Date Title
IL149374A0 (en) New use and novel n-azabicyclo-amide derivatives
HK1042084B (en) Substituted benzimidazoles and their preparation and use
HUP0101172A3 (en) Ortho-anthranilamide derivatives and their use as anti-coagulants
IL190220A0 (en) Novel composition and use
GB9813271D0 (en) Composition and use
ZA200101933B (en) Novel composition and use
HUP0101475A3 (en) 4,5,6 and 7-indole and indoline derivatives, their preparation and use
HUP0103636A3 (en) 2-methyl-thieno-benzodiazepine formulation and its use
AU7659998A (en) N-triazolyl-2-indolecarboxamides and their use as cck-a agonists
AU1607299A (en) Substituted amidinoaryl derivatives and their use as anticoagulants
AU1608399A (en) Substituted amidinoaryl derivatives and their use as anticoagulants
EG22491A (en) Rest-breaking composition and use thereof
EP1023269A4 (en) Beta3-adrenoreceptor agonists, agonist compositions and methods of using
IL130752A0 (en) Polymer composition its preparation and use thereof
AU1937300A (en) Indole derivatives and their use as 5-HT1F agonists
IL131158A0 (en) 4-Aminoalkoxy-1h-benzimidazole derivatives their preparation and their use as dopamine autoreceptor (d2) agonists
EP1229913A4 (en) Substituted 1-benzazepines and derivatives thereof
IL139962A0 (en) 4,5,6 and 7-indole and indoline derivatives, their preparation and use
PL355845A1 (en) Substituted isoquinoline derivatives and their use as inticonvulsants
AU1809595A (en) Phenylpyrrole derivatives and their use as dopamine d3 antagonists
IL131156A0 (en) 4-Aminoalkyl-1,3-dihydrobenzoimidazol-2-one derivatives their preparation and their use as dopamine autoreceptor (d2) agonists
IL131157A0 (en) 4-Aminoalkoxy-1,3-dihydrobenzoimidazol-2-thione derivatives their preparation and their use as dopamine autoreceptor (d2) agonists
GB2324090B (en) 5,6-O-alkylidene glucono-1(4)-lactones and derivatives thereof,their preparation and use
HK1060878A1 (en) Dioxino derivatives and their use as dopamine agonists
GB9805172D0 (en) Composition and use